Anebulo Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 22NW, LP | 05/14/2025 | 15.47 M | $20.11 M | 0.00% | 37.65% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 3.04 M | $3.95 M | 0.00% | 7.39% |
| MANGROVE PARTNERS | 05/15/2025 | 2.53 M | $3.28 M | 0.00% | 6.15% |
| MORGAN STANLEY | 05/15/2025 | 399.22 K | $518.99 K | -4.95% | 0.97% |
| LVW ADVISORS, LLC | 04/09/2025 | 349.62 K | $454.50 K | -44.73% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 205.42 K | $267.08 K | 124.89% | 0.50% |
| VANGUARD GROUP INC | 05/09/2025 | 204.55 K | $265.91 K | 32.79% | 0.50% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 158.97 K | $206.66 K | 100.00% | 0.39% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 157.72 K | $205.04 K | 0.00% | 0.38% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 47.95 K | $62.34 K | 100.00% | 0.12% |
| HRT FINANCIAL LP | 05/15/2025 | 23.16 K | $30.00 K | 100.00% | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 18.84 K | $24.49 K | 0.00% | 0.05% |
| CITADEL ADVISORS LLC | 05/15/2025 | 11.17 K | $14.52 K | 100.00% | 0.03% |
| BLACKROCK, INC. | 05/02/2025 | 5.76 K | $7.49 K | 46.68% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 3.54 K | $4.60 K | 6.37% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 3.45 K | $4.48 K | 4,436.84% | 0.01% |
| JPMORGAN CHASE & CO | 05/12/2025 | 8 | $10 | -11.11% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 1 | $1 | -96.00% | 0.00% |
| KING LUTHER CAPITAL MANAGEMENT CORP | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anebulo Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Anebulo Pharmaceuticals, Inc.. The most heavily invested institutionals were:
22NW, LP: 15.47 M
Nantahala Capital Management, LLC: 3.04 M
MANGROVE PARTNERS: 2.53 M
MORGAN STANLEY: 399,219
LVW Advisors, LLC: 349,617
GEODE CAPITAL MANAGEMENT, LLC: 205,418
55.05% of Anebulo Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 22.62 M shares in the last 24 months. This purchase volume represents approximately $38.00 M in transactions.